These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2966782

  • 1. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF, Guo YZ, Billings J, Xu X, Mach RH, Blau M, Ackerhalt RE.
    Int J Rad Appl Instrum B; 1988; 15(2):195-201. PubMed ID: 2966782
    [Abstract] [Full Text] [Related]

  • 2. Preparation and biodistribution of [125I]IBZP: a potential CNS D-1 dopamine receptor imaging agent.
    Kung HF, Billings JJ, Guo YZ, Blau M, Ackerhalt R.
    Int J Rad Appl Instrum B; 1988; 15(2):187-93. PubMed ID: 2966781
    [Abstract] [Full Text] [Related]

  • 3. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties].
    Matsumura K, Toyama H, Nakashima H, Ichise M, Kurami M, Nakagawa T, Maeda H, Takeuchi A, Koga S.
    Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224
    [Abstract] [Full Text] [Related]

  • 4. Comparison of in vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain.
    Kung HF, Billings JJ, Guo YZ, Mach RH.
    Int J Rad Appl Instrum B; 1988 May; 15(2):203-8. PubMed ID: 2966783
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, Alavi A.
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [Abstract] [Full Text] [Related]

  • 6. In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
    Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC.
    Life Sci; 1988 Jan; 42(21):2097-104. PubMed ID: 3260318
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H, Tanahashi K, Kinoshita T, Iida Y, Magata Y, Yokoyama A.
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [Abstract] [Full Text] [Related]

  • 8. Comparison of in vivo dopamine D2 receptor binding of [(123)I]AIBZM and [(123)I]IBZM in rat brain.
    Li H, Gildehaus FJ, Dresel S, Patt JT, Shen M, Zhu T, Liu B, Tang Z, Tatsch K, Hahn K.
    Nucl Med Biol; 2001 May; 28(4):383-9. PubMed ID: 11395310
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, de Bruin K, van Royen EA.
    Int J Rad Appl Instrum B; 1991 May; 18(8):837-46. PubMed ID: 1839302
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF, Kasliwal R, Pan SG, Kung MP, Mach RH, Guo YZ.
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
    Murphy RA, Kung HF, Kung MP, Billings J.
    J Med Chem; 1990 Jan; 33(1):171-8. PubMed ID: 2136916
    [Abstract] [Full Text] [Related]

  • 12. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
    Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A.
    J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
    [Abstract] [Full Text] [Related]

  • 13. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
    Kung HF, Alavi A, Chang W, Kung MP, Keyes JW, Velchik MG, Billings J, Pan S, Noto R, Rausch.
    J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.
    Neuroimage; 2005 Feb 01; 24(3):822-31. PubMed ID: 15652317
    [Abstract] [Full Text] [Related]

  • 15. [A fundamental study on accumulation of [125I]IBZM in the rat striatum and on effect of non-labeled ligand].
    Ishikawa N, Nakamura T, Motoji N, Satou M, Takeda T, Wu J, Shigematsu A.
    Kaku Igaku; 1995 Jan 01; 32(1):81-6. PubMed ID: 7897871
    [Abstract] [Full Text] [Related]

  • 16. The toxicity and mutagenicity of S-3-iodo-N-(1-ethyl-2-pyrrolidinyl)methyl-2-hydroxy-6-methoxybenzamide (IBZM), a new CNS D-2 dopamine receptor imaging agent.
    Kostyniak PJ, Brenner JS, Maccubbin AE, Nakeeb S, Kasliwal R, Kung HF.
    Drug Chem Toxicol; 1988 Jan 01; 11(4):433-42. PubMed ID: 2977324
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
    Meyer PT, Salber D, Schiefer J, Cremer M, Schaefer WM, Kosinski CM, Langen KJ.
    Nucl Med Biol; 2008 Jul 01; 35(5):543-8. PubMed ID: 18589298
    [Abstract] [Full Text] [Related]

  • 18. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C, Toska K, Friberg L, Holm S, Angelo HR, Knudsen GM.
    J Cereb Blood Flow Metab; 2001 Jan 01; 21(1):92-7. PubMed ID: 11149673
    [Abstract] [Full Text] [Related]

  • 19. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E.
    J Neural Transm Gen Sect; 1995 Jan 01; 99(1-3):187-93. PubMed ID: 8579804
    [Abstract] [Full Text] [Related]

  • 20. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
    Leslie WD, Abrams DN, Greenberg CR, Hobson D.
    J Nucl Med; 1996 Oct 01; 37(10):1589-91. PubMed ID: 8862288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.